About Climb: Climb Bio is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. Our product candidates include, budoprutug, an anti-CD19 monoclonal antibody that presents us with an exciting opportunity given its broad potential applicability across a number of B-cell mediated diseases, including systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy and CLYM116, an anti-APRIL monoclonal antibody in development for IgA nephropathy. At Climb Bio, our team has a knack for seeing what no one else sees—and a drive to achieve results no one expects. We are seeking an experienced, self-motivated Senior Clinical Trial Manager to lead end-to-end delivery of Phase 1 – 3 studies, with immediate emphasis on owning Phase 1/Phase 2 execution and contributing to the development of scalable clinical operations processes. Reporting to the Director of Clinical Operations, this person will play a critical role in enabling Climb to deliver on its mission.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level